AMICUS THERAPEUTICS INC. - COMMON STOCK
10,09
14-ноября-24 15:45:00
15 мин. задержка
Акции
-0,28
-2,70%
Сегодняшний диапазон
10,06 - 10,43
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
Amicus Therapeutics Announces Approval and Launch of New Pompe Disease Therapy in the United Kingdom
15 авг 2023 06:00:00 Источник Nasdaq GlobeNewswire
-
Amicus Therapeutics Announces Second Quarter 2023 Financial Results and Corporate Updates
08 авг 2023 06:00:01 Источник Nasdaq GlobeNewswire
-
Amicus Therapeutics to Announce Second Quarter 2023 Financial Results on August 8, 2023
31 июл 2023 06:00:00 Источник Nasdaq GlobeNewswire
-
Amicus Therapeutics Announces Approval and Launch of New Pompe Disease Therapy in the European Union
27 июн 2023 06:00:00 Источник Nasdaq GlobeNewswire
-
Amicus Therapeutics Announces First Quarter 2023 Financial Results and Corporate Updates
10 май 2023 06:00:02 Источник Nasdaq GlobeNewswire
-
Amicus Therapeutics to Present at the Bank of America 2023 Health Care Conference
02 май 2023 06:00:01 Источник Nasdaq GlobeNewswire
-
Amicus Therapeutics to Announce First Quarter 2023 Financial Results on May 10, 2023
01 май 2023 06:00:01 Источник Nasdaq GlobeNewswire
-
26 апр 2023 12:00:33 Источник Nasdaq GlobeNewswire
-
27 мар 2023 06:00:09 Источник Nasdaq GlobeNewswire
-
Amicus Therapeutics Announces Full-Year 2022 Financial Results and Corporate Updates
01 мар 2023 06:00:02 Источник Nasdaq GlobeNewswire
-
Amicus Therapeutics to Present at the Cowen 43rd Annual Health Care Conference
27 фев 2023 06:00:00 Источник Nasdaq GlobeNewswire
-
22 фев 2023 16:00:08 Источник Nasdaq GlobeNewswire
-
Amicus Therapeutics to Announce Full-Year 2022 Financial Results on March 1, 2023
14 фев 2023 06:00:00 Источник Nasdaq GlobeNewswire
-
Amicus Therapeutics Announces Presentations and Posters at the 19th Annual WORLDSymposium™ 2023
13 фев 2023 06:00:00 Источник Nasdaq GlobeNewswire
-
Amicus Therapeutics to Present at the SVB Securities Global Biopharma Conference
08 фев 2023 06:00:00 Источник Nasdaq GlobeNewswire
-
Amicus Therapeutics Reports Preliminary 2022 Revenue and Provides 2023 Strategic Outlook
09 янв 2023 06:00:01 Источник Nasdaq GlobeNewswire
-
Amicus Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference
03 янв 2023 06:00:01 Источник Nasdaq GlobeNewswire
-
16 дек 2022 07:10:56 Источник Nasdaq GlobeNewswire
-
Amicus Therapeutics to Present at the Stifel 2022 Healthcare Conference
15 ноя 2022 06:00:00 Источник Nasdaq GlobeNewswire
-
Amicus Therapeutics Provides EU Regulatory Update for AT-GAA
07 ноя 2022 11:20:00 Источник Nasdaq GlobeNewswire